NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

Kodu・Aktsiate loetelu・Sonos Inc

Sonos Inc

Suletud

SektorTehnoloogia

13.6 0.07

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.43

Max

13.75

Põhinäitajad
By Trading Economics
Sissetulek	132M 94M
Müük	258M 546M
Aktsiakasum	0.93
Kasumimarginaal	17.19
Töötajad	1,404
EBITDA	134M 116M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+32.55% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	6. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-224M 1.6B
Eelmine avamishind	13.53
Eelmine sulgemishind	13.6

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

9.36 / N/A Toetus ja vastupanu

Sonos Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

6. apr 2026, 23:58 UTC

Market Talk

Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk

Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

6. apr 2026, 14:20 UTC

Market Talk

Uudisväärsed sündmused

High Bar Seen for Bank of Canada to Lift Rates Despite Oil's Spike -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Sonos Inc Prognoos

Hinnasiht

By TipRanks

32.55% tõus

12 kuu keskmine prognoos

Keskmine 18 USD 32.55%

Kõrge 18 USD

Madal 18 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Sonos Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Sonos Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.36 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Sonos Inc

Sonos, Inc., together with its subsidiaries, designs, develops, manufactures, and sells audio products and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers wireless, portable, and home theater speakers; and headphones, components, and accessories. It offers its products through physical stores, websites, online retailers, and custom installers. The company was formerly known as Rincon Audio, Inc. and changed its name to Sonos, Inc. in May 2004. Sonos, Inc. was incorporated in 2002 and is headquartered in Santa Barbara, California.